Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Industry Summary Page

Industry: pharmaceuticals
Penalty Total since 2000: $116,245,163,450
Number of Records: 1,270
Note: The totals include only those entries matched to a parent company. The industry designation is the primary one for the parent's operations overall. The totals are adjusted to account for the fact that each parent's entries may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. They are also adjusted to reflect cases in which federal and state or local agencies cooperated and issued separate announcements of the outcome. Duplicate or overlapping penalty amounts are marked with an asterisk in the individual records list below.
Top 10 Current Parent CompaniesTotal Penalty $Number of Records
Johnson & Johnson$24,497,162,77088
Pfizer$10,948,368,52398
Merck$10,710,400,03189
Teva Pharmaceutical Industries$10,242,576,79696
GlaxoSmithKline$9,572,803,40650
Purdue Pharma$9,278,372,78711
AbbVie$7,560,456,40484
Takeda Pharmaceutical$3,987,516,44732
Endo International$3,311,990,66730
Eli Lilly$2,831,299,67626

Individual Penalty Records:

Click on the company or penalty amount for more information on each case. Click on the parent name to reach the summary page for that parent company.

Download results as CSV or XML or Save your search (Click here for information on download subscriptions)
CompanyCurrent ParentPrimary Offense TypeYearAgencyPenalty Amount sort icon
NovartisNovartiswage and hour violation2012private lawsuit-federal$99,000,000
Janssen PharmaceuticalsJohnson & Johnsonoff-label or unapproved promotion of medical products2022WV-AG$99,000,000
Mylan Laboratories, Inc.Viatrisconsumer protection violation2000FTC$100,000,000
Mallinckrodt ARD IncMallinckrodtprice-fixing or anti-competitive practices2017FTC$100,000,000
Astellas Pharma US Inc.Astellas PharmaFalse Claims Act and related2019DOJ_CIVIL$100,000,000
Bristol-Myers Squibb Co.Bristol-Myers Squibbprice-fixing or anti-competitive practices2003MULTI-AG$100,000,000
Mallinckrodt plcMallinckrodtprice-fixing or anti-competitive practices2017MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $100,000,000
Organon USA Inc.Organon & Co.drug or medical equipment safety violation2018private lawsuit-federal$100,000,000
GlaxoSmithKline PLCGlaxoSmithKlineprice-fixing or anti-competitive practices2005private lawsuit-federal$100,000,000
Indivior Inc.Indivior PLCprice-fixing or anti-competitive practices2023MULTI-AG$102,500,000
Novartis Pharmaceuticals Corp.Novartiskickbacks and bribery2020MULTI-AG$103,000,000
GlaxoSmithKline, LLCGlaxoSmithKlinekickbacks and bribery2014MULTI-AG$105,000,000
Mylan Laboratories et al.Viatrisprice-fixing or anti-competitive practices2000MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $108,000,000
Sanofi-Aventis U.S. Inc.SanofiFalse Claims Act and related2012DOJ_CIVIL$109,000,000
AstraZenecaAstraZenecaFalse Claims Act and related2018TX-AG$110,000,000
Novartis AGNovartisForeign Corrupt Practices Act2020SEC$112,800,000
Avanir PharmaceuticalsOtsuka PharmaceuticalFalse Claims Act and related2019DOJ_CIVIL$115,874,895
Cephalon Inc.Teva Pharmaceutical Industriesoff-label or unapproved promotion of medical products2008MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $116,000,000
Johnson & JohnsonJohnson & Johnsondrug or medical equipment safety violation2019MULTI-AG$116,860,000
Mylan Pharmaceuticals and UDL LaboratoriesViatrisFalse Claims Act and related2009DOJ_CIVIL$118,000,000
Mylan Pharmaceuticals, Inc.ViatrisFalse Claims Act and related2009MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $118,000,000
Actavis Mid-Atlantic LLCTeva Pharmaceutical Industriesprice-fixing or anti-competitive practices2011private lawsuit-federal$118,614,000
Johnson & JohnsonJohnson & Johnsondrug or medical equipment safety violation2019MULTI-AG$120,000,000
Allergan PLCAbbVieprice-fixing or anti-competitive practices2020private lawsuit-federal$120,000,000
King PharmaceuticalsPfizerFalse Claims Act and related2005DOJ_CIVIL$124,000,000
King PharmaceuticalsPfizerFalse Claims Act and related2006MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $124,000,000
Warner Chilcott PLCAbbVieoff-label or unapproved promotion of medical products2015FDA$125,000,000
CephalonTeva Pharmaceutical Industriesconsumer protection violation2016MULTI-AG$125,000,000
Abbott Laboratories Inc.AbbVieFalse Claims Act and related2010DOJ_CIVIL$126,500,000
Novartis AGNovartisprice-fixing or anti-competitive practices2023private lawsuit-federal$126,850,000
Hoffmann-La RocheRocheprice-fixing or anti-competitive practices2000private lawsuit-federal$130,000,000
Allergan Ltd. et al.AbbVieoff-label or unapproved promotion of medical products2022FL-AG$134,200,000
Hoffman-LaRocheRocheprice-fixing or anti-competitive practices2000MULTI-AG$142,494,000
Valeant Pharmaceuticals International, Inc.Bausch Healthinvestor protection violation2017MULTI-AG$145,000,000
Impax Laboratories, Inc.Amneal Pharmaceuticalsprice-fixing or anti-competitive practices2022private lawsuit-federal$145,000,000
Forest Pharmaceuticals Inc.AbbVieFalse Claims Act and related2010USAO$149,000,000
Johnson & JohnsonJohnson & Johnsonoff-label or unapproved promotion of medical products2024WA-AG$149,500,000
GlaxoSmithKlineGlaxoSmithKlineFalse Claims Act and related2005DOJ_CIVIL$150,000,000
Bristol-Myers Squibb CompanyBristol-Myers Squibbaccounting fraud or deficiencies2004SEC$150,000,000
Janssen Pharmaceuticals, Inc.Johnson & Johnsonproduct safety violation2022private lawsuit-federal$150,000,000
GlaxoSmithKline PLCGlaxoSmithKlineprice-fixing or anti-competitive practices2013private lawsuit-federal$150,000,000
Lupin Pharmaceuticals Inc.Lupin Limitedprice-fixing or anti-competitive practices2022private lawsuit-federal$150,000,000
Sandoz Inc.Sandoz Groupprice-fixing or anti-competitive practices2011private lawsuit-federal$150,000,000
TAP Pharmaceutical ProductsTakeda Pharmaceuticalprice-fixing or anti-competitive practices2005private lawsuit-federal$150,000,000
Hikma PharmaceuticalsHikma Pharmaceuticalsoff-label or unapproved promotion of medical products2024MULTI-AG$150,000,000
Par Pharmaceuticals, Inc.Endo InternationalFalse Claims Act and related2011MULTI-AG$154,000,000
Johnson & JohnsonJohnson & Johnsonoff-label or unapproved promotion of medical products2012TX-AG$158,000,000
Purdue Frederick Company Inc.Purdue PharmaFalse Claims Act and related2007MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $160,000,000
SB Pharmco Puerto Rico Inc.GlaxoSmithKlinedrug or medical equipment safety violation2010MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $163,560,000
Forest Pharmaceuticals Inc.AbbVieoff-label or unapproved promotion of medical products2011FDA$164,000,000
Teva Pharmaceuticals Inc.Teva Pharmaceutical IndustriesFalse Claims Act and related2010MULTI-AG$169,000,000
Endo Health SolutionEndo Internationaloff-label or unapproved promotion of medical products2014MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $173,000,000
Novartis CorporationNovartisemployment discrimination2010private lawsuit-federal$175,000,000
GlaxoSmithKlineGlaxoSmithKlineprice-fixing or anti-competitive practices2004private lawsuit-federal$175,000,000
Janssen Pharmaceuticals, Inc.Johnson & Johnsonoff-label or unapproved promotion of medical products2012MULTI-AG$181,000,000
Sandoz Inc.Sandoz GroupFalse Claims Act and related2021DOJ_CIVIL$185,000,000
Bristol-Myers SquibbBristol-Myers SquibbFalse Claims Act and related2008MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $187,000,000
Aventis Pharmaceuticals Inc.SanofiFalse Claims Act and related2007DOJ_CIVIL$190,000,000
Warner-LambertPfizeroff-label or unapproved promotion of medical products2004MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $190,000,000
Pfizer Inc.Pfizerprice-fixing or anti-competitive practices2014private lawsuit-federal$190,000,000
Endo Health Solutions Inc.Endo Internationaloff-label or unapproved promotion of medical products2014FDA$192,700,000
Sandoz Inc.Sandoz Groupprice-fixing or anti-competitive practices2020DOJ_ANTITRUST$195,000,000
AstraZenecaAstraZenecadrug or medical equipment safety violation2010private lawsuit-federal$198,000,000
Allergan Finance LLCAbbVieoff-label or unapproved promotion of medical products2021NY-AG$200,000,000
Merck Sharp & Dohme Corp.Merckoff-label or unapproved promotion of medical products2012MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $201,975,000
Elan Corporation PLCPerrigooff-label or unapproved promotion of medical products2010FDA$203,000,000
United Therapeutics CorporationUnited TherapeuticsFalse Claims Act and related2017DOJ_CIVIL$210,000,000
Taro Pharmaceuticals USA, Inc.Sun PharmaceuticalsFalse Claims Act and related2021DOJ_CIVIL$213,200,000
AstraZeneca Pharmaceuticals LPAstraZenecaoff-label or unapproved promotion of medical products2010MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $218,092,993
Bristol-Myers Squibb CompanyBristol-Myers Squibbprice-fixing or anti-competitive practices2003private lawsuit-federal$220,000,000
Teva Pharmaceutical Industries Ltd.Teva Pharmaceutical Industriesoff-label or unapproved promotion of medical products2022TX-AG$225,000,000
Barr Laboratories Inc.Teva Pharmaceutical Industriesprice-fixing or anti-competitive practices2017private lawsuit-state$225,000,000
Novartis Hellas S.A.C.I. et al.NovartisForeign Corrupt Practices Act2020DOJ_CRIMINAL$233,000,000
Teva Pharmaceutical Industries LimitedTeva Pharmaceutical IndustriesForeign Corrupt Practices Act2016SEC$236,000,000
Gilead SciencesGilead Sciencesprice-fixing or anti-competitive practices2024private lawsuit-federal$246,750,000
Abbott LaboratoriesAbbVieprice-fixing or anti-competitive practices2009private lawsuit-federal$250,000,000
Wyeth Pharmaceuticals, Inc.Pfizeroff-label or unapproved promotion of medical products2013MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $257,400,000
Mallinckrodt ARD LLCMallinckrodtFalse Claims Act and related2022DOJ_CIVIL$260,000,000
Serono Inc.Merck KGaA (EMD)off-label or unapproved promotion of medical products2005MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $262,000,000
Mylan N.V.Viatrisprice-fixing or anti-competitive practices2022private lawsuit-federal$264,000,000
RanbaxySun Pharmaceuticalsdrug or medical equipment safety violation2013MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $266,729,715
Purdue PharmaPurdue PharmaControlled Substances Act violation2019OK-AG$270,000,000
Teva Pharmaceuticals Industries Ltd.Teva Pharmaceutical Industriesproduct safety violation2012private lawsuit-federal$270,000,000
Teva Pharmaceuticals USA, Inc.Teva Pharmaceutical Industriesprice-fixing or anti-competitive practices2023DOJ_ANTITRUST$275,000,000
Teva Pharmaceutical IndustriesTeva Pharmaceutical Industriesoff-label or unapproved promotion of medical products2022FL-AG$278,826,499
Dey Inc.ViatrisFalse Claims Act and related2010DOJ_CIVIL$280,000,000
Roxane Laboratories Inc.Hikma PharmaceuticalsFalse Claims Act and related2010DOJ_CIVIL$280,000,000
Celgene Corp.Bristol-Myers SquibbFalse Claims Act and related2017USAO$280,000,000
Teva Pharmaceutical Industries LtdTeva Pharmaceutical IndustriesForeign Corrupt Practices Act2016DOJ_CRIMINAL$283,177,348
PfizerPfizerdrug or medical equipment safety violation2013private lawsuit-federal$288,000,000
MerckMerckFalse Claims Act and related2008MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $290,000,000
Schering-Plough CorporationMerckkickbacks and bribery2004MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $292,969,482
Bristol-Myers SquibbBristol-Myers Squibbfraud2005USAO$300,000,000
Indivior plcIndivior PLCoff-label or unapproved promotion of medical products2021MULTI-AG$300,000,000
Daiichi Sankyo Inc.Daiichi Sankyoproduct safety violation2017private lawsuit-federal$300,000,000
Bausch Health Companies Inc.Bausch Healthprice-fixing or anti-competitive practices2022private lawsuit-federal$300,000,000
Johnson and JohnsonJohnson & Johnsondrug or medical equipment safety violation2023CA-AG$302,000,000
Teva Pharmaceuticals, Ltd.Teva Pharmaceutical Industriesoff-label or unapproved promotion of medical products2022NY-AG$313,343,793
Pfizer, Inc.Pfizerkickbacks and bribery2009MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $331,485,170
Abbott LaboratoriesAbbVieoff-label or unapproved promotion of medical products2012MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $339,148,643
Schering-Plough CorporationMerckkickbacks and bribery2004DOJ_CIVIL$345,000,000
(*): Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting.